← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-10 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleRochePhase 2

bevacizumab, bicalutamide and goserelin (bevacizumab, bicalutamide and goserelin)

Prostate Cancer · Prostate Cancer

#ProstateCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

bevacizumab, carboplatin and paclitaxel (bevacizumab, carboplatin and paclitaxel)

Non-small Cell Lung Cancer (NSCLC) · Non-small Cell Lung Cancer (NSCLC)

#Non-smallCellLungCancerNSCLC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

bevacizumab, pemetrexed, cisplatin (bevacizumab, pemetrexed, cisplatin)

Lung Cancer · Lung Cancer

#LungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity Hospital, CaenPhase 2

bevacuzimab spray (bevacuzimab spray)

Telangiectasia, Hereditary Hemorrhagic · Telangiectasia, Hereditary Hemorrhagic

#TelangiectasiaHereditaryHemorrha#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleAmgenPhase 1

blinatumomab and auto-HSCT "sandwich " strategy (blinatumomab and auto-HSCT "sandwich " strategy)

B-cell Acute Lymphoblastic Leukemia · B-cell Acute Lymphoblastic Leukemia

#B-cellAcuteLymphoblasticLeukemia#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSingapore General HospitalPhase 1

bortezomib, rituximab, ifosphamide, etoposide, carboplatin (bortezomib, rituximab, ifosphamide, etoposide, carboplatin)

Diffuse Large B-Cell Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

cTACE+Atirizumab+Bevacizumab (cTACE+Atirizumab+Bevacizumab)

Hepatocellular Carcinoma · Hepatocellular Carcinoma

#HepatocellularCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleCentre Francois BaclesseApproved

nivolumab (Opdivo, cabozantinib and nivolumab)

Renal Cell Carcinoma (Kidney Cancer); Metastatic Renal Cell Carcinoma · Renal Cell Carcinoma (Kidney Cancer)

#RenalCellCarcinomaKidneyCancer#Antibody#Approved#항체#면역항체+3
효능 ORR 25%임상시험 1상태 RECRUITING
AntibodystaleSichuan Cancer Hospital and Res…Phase 2

cadonilimab+paclitaxel/albumin-bound paclitaxel+carboplatin (cadonilimab+paclitaxel/albumin-bound paclitaxel+carboplatin)

NSCLC · NSCLC

#NSCLC#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleCancer Institute and Hospital, …Phase 2

cadonilimab，bevacizumab，docetaxel (cadonilimab，bevacizumab，docetaxel)

Stage IVB Lung Cancer; Non-Squamous · Stage IVB Lung Cancer

#StageIVBLungCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

capecitabine and oxaliplatin + cetuximab (capecitabine and oxaliplatin + cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

trastuzumab (Herceptin, capecitabine and trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 2

trastuzumab (Herceptin, carboplatin and paclitaxel and or without trastuzumab)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleThe Netherlands Cancer InstitutePhase 1

atezolizumab (Tecentriq, carbplatin, cyclophophamide, atezolizumab)

Breast Cancer; Cervix Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleShanghai Zhongshan HospitalPhase 2

cardonilizumab (cardonilizumab)

Biliary Tract Cancer; Candonilimab · Biliary Tract Cancer

#BiliaryTractCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 3

KDD (carfilzomib/daratumumab/dexamethasone, carfilzomib/daratumumab/dexamethasone (KDD))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

cetuximab (CTX, cetuximab, cetuximab (CTX) or nimotuzumab (NTZ))

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cohort C2 Only (cetuximab, cetuximab (Cohort C2 Only))

Advanced Solid Tumors; Metastatic Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

cetuximab + docetaxel + cisplatin (cetuximab + docetaxel + cisplatin)

Esophageal Cancer · Esophageal Cancer

#EsophagealCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

docetaxel, cisplatin, 5-fluorouracil (cetuximab and chemotherapy, cetuximab and chemotherapy (docetaxel, cisplatin, 5-fluorouracil))

Esophageal Carcinoma · Esophageal Carcinoma

#EsophagealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE

83 / 92 페이지

← 이전다음 →